Cited 21 times in
The RON Receptor Tyrosine Kinase in Pancreatic Cancer Pathogenesis and Its Potential Implications for Future Targeted Therapies
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강창무 | - |
dc.date.accessioned | 2015-01-06T16:26:43Z | - |
dc.date.available | 2015-01-06T16:26:43Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0885-3177 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/98118 | - |
dc.description.abstract | Pancreatic cancer remains a devastating disease with a mortality rate that has not changed substantially in decades. Novel therapies are therefore desperately needed. The RON receptor tyrosine kinase has been identified as an important mediator of KRAS oncogene addiction and is overexpressed in the majority of pancreatic cancers. Preclinical studies show that inhibition of RON function decreases pancreatic cancer cell migration, invasion, and survival and can sensitize pancreatic cancer cells to chemotherapy. This article reviews the current state of knowledge regarding RON biology and pancreatic cancer and discusses its potential as a therapeutic target. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 183~189 | - |
dc.relation.isPartOf | PANCREAS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Antibodies, Monoclonal/therapeutic use* | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Cell Movement/drug effects | - |
dc.subject.MESH | Cell Proliferation/drug effects | - |
dc.subject.MESH | Forecasting | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Molecular Targeted Therapy/methods* | - |
dc.subject.MESH | Molecular Targeted Therapy/trends | - |
dc.subject.MESH | Pancreatic Neoplasms/drug therapy* | - |
dc.subject.MESH | Pancreatic Neoplasms/metabolism | - |
dc.subject.MESH | Pancreatic Neoplasms/pathology | - |
dc.subject.MESH | Receptor Protein-Tyrosine Kinases/antagonists & inhibitors* | - |
dc.subject.MESH | Receptor Protein-Tyrosine Kinases/immunology | - |
dc.subject.MESH | Receptor Protein-Tyrosine Kinases/metabolism | - |
dc.subject.MESH | Signal Transduction/drug effects | - |
dc.title | The RON Receptor Tyrosine Kinase in Pancreatic Cancer Pathogenesis and Its Potential Implications for Future Targeted Therapies | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학) | - |
dc.contributor.googleauthor | Chang Moo Kang | - |
dc.contributor.googleauthor | Michele L. Babicky | - |
dc.contributor.googleauthor | Andrew M. Lowy | - |
dc.identifier.doi | 10.1097/MPA.0000000000000088 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00088 | - |
dc.relation.journalcode | J02463 | - |
dc.identifier.eissn | 1536-4828 | - |
dc.identifier.pmid | 24518495 | - |
dc.identifier.url | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006676-201403000-00003&LSLINK=80&D=ovft | - |
dc.subject.keyword | pancreatic cancer | - |
dc.subject.keyword | RON receptor | - |
dc.subject.keyword | tyrosine kinase | - |
dc.contributor.alternativeName | Kang, Chang Moo | - |
dc.contributor.affiliatedAuthor | Kang, Chang Moo | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 43 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 183 | - |
dc.citation.endPage | 189 | - |
dc.identifier.bibliographicCitation | PANCREAS, Vol.43(2) : 183-189, 2014 | - |
dc.identifier.rimsid | 54899 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.